Midostaurin

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Midostaurin

CAS No. : 120685-11-2

MCE 国际站：Midostaurin

产品活性：Midostaurin (PKC412; CGP 41251) 是一种多靶点蛋白激酶抑制剂，抑制 PKCα/β/γ，Syk，Flk-1，Akt，PKA，c-Kit，c-Fgr，c-Src，FLT3，PDFRβ 和 VEGFR1/2 的 IC₅₀ 值范围为 22-500 nM。

研究领域：Epigenetics | TGF-beta/Smad

作用靶点：PKC

In Vitro: Midostaurin (PKC412) shows a broad antiproliferative activity against various tumor and normal cell lines in vitro, and is able to reverse the Pgp-mediated multidrug resistance of tumor cells in vitro. Exposure of cells to Midostaurin (PKC412) results in a dose-dependent increase in the G2/M phase of the cell cycle concomitant with increased polyploidy, apoptosis and enhanced sensitivity to ionizing radiation. Midostaurin (PKC412) induces substantial inhibition of KIT-, Lyn-, and STAT5 activity, but does not suppress Btk in HMC-1 cells and primary neoplastic mast cells. Midostaurin (PKC412) inhibits EN fusion tyrosine kinase in hematopoietic Ba/F3 cells. Midostaurin (PKC412) significantly inhibits EN phosphorylation in M0-91 and IMS-M2 cells in a dose-dependent manner.

In Vivo: Midostaurin (PKC412) strongly inhibits retinal neovascularization as well as laser-induced choroidal neovascularization in murine models. Midostaurin (PKC412) (25 mg/kg, i.p.) protects mouse livers of the K18 Arg90Cys-overexpressing transgenic mice from Fas-induced apoptosis.

相关产品：Covalent Screening Library Plus | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Epigenetics Compound Library | Kinase Inhibitor Library | TGF-beta/Smad Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Drug Repurposing Compound Library | Covalent Screening Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Cytoskeleton Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Targeted Therapy Drug Library | Neurodegenerative Disease-related Compound Library | Rare Diseases Drug Library | Phorbol 12-myristate 13-acetate | Staurosporine | Ionomycin | Go 6983 | Mitoxantrone | Bisindolylmaleimide I | Fasudil Hydrochloride | Sotrastaurin | Enzastaurin | Rottlerin | K-252a | Phorbol 12,13-dibutyrate | Afuresertib | Ro 31-8220 mesylate | Verbascoside | D-erythro-Sphingosine | Ingenol Mebutate | Chelerythrine chloride | CGP60474 | Darovasertib | (-)-Indolactam V | Go6976 | VTX-27 | TPPB | CMPD101 | Decursin | BJE6-106 | Valrubicin

热门产品线：重组蛋白 | 化合物库 | 天然产物 | 染料试剂 | PROTAC | 同位素标记物

Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种TOP期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪前沿的制药及生命科学研究进展，为您提供全球前沿的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。